Kurs & Likviditet
Beskrivning
| Land | Danmark |
|---|---|
| Lista | Large Cap Copenhagen |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
7.2.2022 08:53:38 CET | Demant A/S | Inside information
Company announcement no 2022-02 | 7 February 2022 |
Erroneous publication of two key figures on Demant’s website
Due to an unfortunate error, we published our organic revenue growth and EBIT for 2021 on
www.demant.com on Sunday evening.
The text was as follows:
“Very strong performance in 2021
On Tuesday 8 February 2022, Demant published its Annual Report 2021. Organic revenue for the Group grew by 27% and profitability was strong with operating profit of DKK 3.4 billion.”
There was no further information to be obtained. We confirm the numbers, which are subject to final approval by the auditors and the Board of Directors. Our process for the annual reporting continues as originally planned, and we expect to publish the company announcement and the Annual Report 2021 tomorrow, Tuesday 8 February.
Further information: Søren Nielsen, President & CEO Phone +45 3917 7300 | Other contacts: René Schneider, CFO Mathias Holten Møller, Head of IR Trine Kromann-Mikkelsen, VP Corporate Communication and Relations |
About Demant A/S
Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect with the world around them. In every aspect, from hearing devices, hearing implants, diagnostics to audio and video solutions and hearing care all over the world, Demant is active and engaged. Our innovative technologies and know-how help improve people’s health and hear-ing. We create life-changing differences through hearing health.